Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NSC 628503

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Taxotere (TER) and tax01 (TA) are new antitumour agents currently undergoing clinical evaluation. We studied the antineoplastic… Expand
Is this relevant?
1994
1994
In the late 1960s, a crude alcohol extract from the bark of the Pacific Yew, Taxus brevifolia L., was revealed to be cytotoxic in… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
PURPOSE This phase I study of Taxotere (RP 56976, NSC 628503; docetaxel, Rhône-Poulenc Rorer, Antony, France) was undertaken to… Expand
Is this relevant?
Highly Cited
1993
Highly Cited
1993
Taxotere (N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl Taxol; RP 56976; NSC 628503) is a semisynthetic analogue of Taxol. It is… Expand
Is this relevant?
1993
1993
Taxotere (TER) and taxol (TA) are new antitumour agents currently undergoing clinical evaluation. We studied the antineoplastic… Expand
Is this relevant?
1993
1993
BACKGROUND The new cytostatic agent taxol has clearly demonstrated its effectiveness in ovarian cancer patients. The synthesis of… Expand
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Taxotere (RP 56976, NSC 628503), an analog of taxol, is an inhibitor of depolymerisation of microtubules and is currently in… Expand
Is this relevant?
1992
1992
Taxotere (RP 56976, NSC 628503) is a new semisynthetic analog of taxol (NSC 125973) with promising antitumor activity in a… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Taxotere (RP 56976; NSC 628503; N-debenzoyl-N-tert-butoxycarbonyl-10-deacetyl taxol) is a new microtubule stabilizing agent. It… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?